\ Upcoming Events ASX Linkedin Twitter About Viralytics Overview Company History Locations Management Team Dr Malcolm McColl Assoc. Prof. Darren Shafren Mr Robert Vickery Dr Jennifer Rosenthal Ms Rae Saltzstein Board of Directors Mr Paul Hopper Dr Leonard Post Mr Peter Turvey Dr Malcolm McColl Clinical Advisory Board Our Pipeline CAVATAK® About CAVATAK® Therapeutic Approach The Opportunity Clinical Trials Clinical Trials – Phase 1 KEYNOTE-200 Clinical Trials – Phase 1 MITCI Clinical Trials – Phase 1 CAPRA Clinical Trials – Phase 1 in NSCLC Clinical Trials – Phase 2 CALM Clinical Trials – Phase 1 CANON Scientific Presentations Scientific Presentations 2018 Scientific Presentations 2017 Scientific Presentations 2016 Scientific Presentations 2015 Scientific Presentations 2014 Scientific Presentations 2013 Scientific Presentations 2012 Scientific Presentations 2011 and earlier Pre-clinical Studies Scientific Publications Intellectual Property & Patents Our Other Oncolytic Viruses Investor Centre Investors Home ASX Announcements Company News Financial Reports Analyst Coverage Analyst Coverage 2018 Analyst Coverage 2017 Analyst Coverage 2016 Analyst Coverage 2015 Analyst Coverage 2014 Analyst Coverage 2013 Shareholder Newsletters Corporate Governance Shareholder Meetings News & Events Media In the Media 2018 In the Media 2017 In the Media 2016 In the Media 2015 In the Media 2014 In the Media 2013 Upcoming Events Company News Contact Contact Us Subscribe to Viralytics News Home News & Events Upcoming Events News & Events In the Media Upcoming Events Upcoming Events Viralytics will be attending the following conferences in the near future: Conference Date Viralytics Limited Suite 305, Level 3, 66 Hunter Street Sydney NSW 2000 Australia T: +61 (0)2 9988 4000 F: +61 (0)2 8068 6038 © Viralytics Limited 2018 This information does not take your circumstances into account. Read the relevant ASX releases, financial reports and prospectuses before making an investment decision. Shares in Viralytics Limited, ABN 12 010 657 351, are traded on the Australian Stock Exchange (ASX:VLA) and on the over-the-counter market (OTC: VRACY). × Your browser does not support HTML5 video tag. × × Your browser does not support HTML5 video tag. × Your browser does not support HTML5 video tag. × Your browser does not support HTML5 video tag.